Diagnosis Code C22.0
Information for Medical Professionals
The diagnosis code C22.0 is grouped in the following Diagnostic Related Group(s) (MS-DRG V34.0)
- 435 - MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH MCC
- 436 - MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH CC
- 437 - MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITHOUT CC/MCC
Convert to ICD-9 General Equivalence Map
The ICD-10 and ICD-9 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.
- 155.0 - Mal neo liver, primary (approximate) Approximate Flag
The approximate flag is on, indicating that the relationship between the code in the source system and the code in the target system is an approximate equivalent.
- Adenocarcinoma of liver
- Combined hepatocellular carcinoma and cholangiocarcinoma
- Fibrolamellar hepatocellular carcinoma
- Liver cell carcinoma
Index of Diseases and Injuries
References found for the code C22.0 in the Index of Diseases and Injuries:
- Inclusion Terms: Inclusion terms
List of terms is included under some codes. These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
- Hepatocellular carcinoma
Table of Neoplasms
The code C22.0 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.
Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.
The Tabular must be reviewed for the complete diagnosis code.
Information for Patients
Also called: Hepatocellular carcinoma
Your liver is the largest organ inside your body. It helps your body digest food, store energy, and remove poisons. Primary liver cancer starts in the liver. Metastatic liver cancer starts somewhere else and spreads to your liver.
Risk factors for primary liver cancer include
- Having hepatitis B or C
- Heavy alcohol use
- Having cirrhosis, or scarring of the liver
- Having hemochromatosis, an iron storage disease
- Obesity and diabetes
Symptoms can include a lump or pain on the right side of your abdomen and yellowing of the skin. However, you may not have symptoms until the cancer is advanced. This makes it harder to treat. Doctors use tests that examine the liver and the blood to diagnose liver cancer. Treatment options include surgery, radiation, chemotherapy, or liver transplantation.
NIH: National Cancer Institute
- Abdominal tap (Medical Encyclopedia)
- After chemotherapy - discharge (Medical Encyclopedia)
- Hepatocellular carcinoma (Medical Encyclopedia)
- Liver metastases (Medical Encyclopedia)
- Understanding Chemotherapy - NIH - Easy-to-Read (National Cancer Institute)
- What to Know about External Beam Radiation Therapy - NIH - Easy-to-Read (National Cancer Institute)